Li Bai
Impact in
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Pulmonary Hypertension Research and Treatments
-
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
Papers in
-
- Gastric Cancer Management and Outcomes 6
- Pulmonary Hypertension Research and Treatments 2
- Lung Cancer Diagnosis and Treatment 2
- Lung Cancer Treatments and Mutations 2
- Oncology 10
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 2
- Global Cancer Incidence and Screening 2
- Co-authors
- Guisheng Qian (3 shared papers)Yuxian Bai (4 shared papers)Feng Bi (2 shared papers)Ying Cheng (3 shared papers)Qingxia Fan (2 shared papers)Liwei Wang (2 shared papers)Lin Shen (3 shared papers)Jifang Gong (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Biochemical and Biophysical Research Communications (2 papers)Scientific Reports (2 papers)Oncotarget (2 papers)Preventive Medicine (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li Bai
24 papers receiving 325 citations
Peers
Comparison fields: 5 of 63
- Pulmonary and Respiratory Medicine 145
- Oncology 103
- Gastroenterology 19
- Cancer Research 33
- Computational Mathematics 1
Countries citing papers authored by Li Bai
This map shows the geographic impact of Li Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Bai more than expected).
Fields of papers citing papers by Li Bai
This network shows the impact of papers produced by Li Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Bai. The network helps show where Li Bai may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 75 | |
| 2 | 2017 | 32 | |
| 3 | Safety and efficacy of pegylated liposomal doxorubicin-based adjuvant chemotherapy in patients with stage I-III triple-negative breast cancer. | 2014 | 26 |
| 4 | 2020 | 26 | |
| 5 | 2017 | 26 | |
| 6 | 2010 | 25 | |
| 7 | 2017 | 20 | |
| 8 | 2015 | 19 | |
| 9 | 2015 | 16 | |
| 10 | 2012 | 13 | |
| 11 | 2023 | 8 | |
| 12 | 2017 | 8 | |
| 13 | 2009 | 7 | |
| 14 | 2013 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2013 | 3 | |
| 17 | 2014 | 3 | |
| 18 | Hypertrophic pulmonary osteoarthropathy associated with disease progression in renal cell carcinoma. | 2003 | 3 |
| 19 | 2024 | 2 | |
| 20 | 2014 | 2 |
About Li Bai
Li Bai is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Surgery and Immunology, having authored 28 papers that have together received 328 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Pulmonary Hypertension Research and Treatments (2 papers), HER2/EGFR in Cancer Research (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Advanced Neuroimaging Techniques and Applications (2 papers), Global Cancer Incidence and Screening (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (145 citations), Oncology (103 citations), Gastroenterology (19 citations), Cancer Research (33 citations) and Computational Mathematics (1 citation). Li Bai has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guisheng Qian, Yuxian Bai, Feng Bi, Ying Cheng, Qingxia Fan, Liwei Wang, Lin Shen, Jifang Gong, Shukui Qin and Nong Xu. Their work appears in journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications, Scientific Reports, Oncotarget and Preventive Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.